Literature DB >> 16352704

Hypocretin (orexin) receptor subtypes differentially enhance acetylcholine release and activate g protein subtypes in rat pontine reticular formation.

René Bernard1, Ralph Lydic, Helen A Baghdoyan.   

Abstract

The hypothalamic peptides hypocretin-1 (orexin A) and -2 (orexin B) promote wakefulness by mechanisms that are not well understood. Defects in hypocretinergic neurotransmission underlie the human sleep disorder narcolepsy. Hypocretins alter cell excitability via two receptor subtypes, hypocretin receptor subtype 1 (hcrt-r1) and hypocretin receptor subtype 2 (hcrt-r2). This study aimed to identify G protein subtypes activated by hypocretin in rat pontine reticular nucleus oral part (PnO) and the hypocretin receptor subtype modulating acetylcholine (ACh) release in the PnO. G protein activation was quantified using in vitro [(35)S]guanylyl-5'-O-(gamma-thio)triphosphate autoradiography. ACh release was measured using in vivo microdialysis and high-performance liquid chromatography. Hypocretin-1-stimulated G protein activation was significantly decreased by pertussis toxin, demonstrating that some hypocretin receptors in rat PnO activate inhibitory G proteins. Hypocretin-1-stimulated ACh release was not blocked by pertussis toxin, supporting the conclusion that the hypocretin receptors modulating ACh release in rat PnO activate stimulatory G proteins. Hypocretin-1 and -2 each caused a concentration-dependent increase in ACh release with similar potencies, indicating that hcrt-r2 modulates ACh release in PnO. Hypocretin-1 caused a significantly greater increase in ACh release than hypocretin-2, suggesting a role for hcrt-r1 in the modulation of PnO ACh release. Taken together, these data provide the first evidence that hypocretin receptors in rat PnO signal via inhibitory and stimulatory G proteins and that ACh release in rat PnO is modulated by hcrt-r2 and hcrt-r1. One mechanism by which hypocretin promotes arousal may be to increase ACh release in the pontine reticular formation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16352704     DOI: 10.1124/jpet.105.097071

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  Neuropharmacology of Sleep and Wakefulness.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2010-12

Review 2.  Energy expenditure: role of orexin.

Authors:  Jennifer A Teske; Vijayakumar Mavanji
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

Review 3.  Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention.

Authors:  J Fadel; J A Burk
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

Review 4.  Escape From Oblivion: Neural Mechanisms of Emergence From General Anesthesia.

Authors:  Max B Kelz; Paul S García; George A Mashour; Ken Solt
Journal:  Anesth Analg       Date:  2019-04       Impact factor: 5.108

5.  Neuropharmacology of Sleep and Wakefulness: 2012 Update.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2012-09-04

6.  Thermal nociception is decreased by hypocretin-1 and an adenosine A1 receptor agonist microinjected into the pontine reticular formation of Sprague Dawley rat.

Authors:  Sarah L Watson; Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  J Pain       Date:  2009-12-16       Impact factor: 5.820

Review 7.  Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness.

Authors:  Christopher J Watson; Haideliza Soto-Calderon; Ralph Lydic; Helen A Baghdoyan
Journal:  Sleep       Date:  2008-04       Impact factor: 5.849

8.  Morphine increases acetylcholine release in the trigeminal nuclear complex.

Authors:  Zhenghong Zhu; Heather R Bowman; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep       Date:  2008-12       Impact factor: 5.849

9.  Hypocretinergic and non-hypocretinergic projections from the hypothalamus to the REM sleep executive area of the pons.

Authors:  Pablo Torterolo; Sharon Sampogna; Michael H Chase
Journal:  Brain Res       Date:  2012-10-30       Impact factor: 3.252

10.  Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network.

Authors:  Bin Wang; Zhi-Bing You; Roy A Wise
Journal:  Biol Psychiatry       Date:  2009-02-28       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.